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ABSTRACT 
Ayurveda is a comprehensive and systematic medicinal system, originated in India. It takes into 
consideration all aspects of health, including mental, physical and social components. According to 
the principles of Ayurvedic medication, heavy metals possess considerable therapeutic properties 
and can be administered to the patients after being processed properly as mentioned within the 
Rasashastra, in prescribed quantities. However, improper manufacturing processes might lead to 
higher levels of heavy metals remaining in the final product which may be dangerous. They may also 
be present as impurity rather than being added willfully. Heavy metals possess tendency to 
accumulate in vital organs and hence, pose a particular health risk. The presence of impurities in 
drug samples, whether herbal or pharmaceutical, is of great concern, not only because some 
contaminants are inherently toxic, but also they may negatively affect the stability of the drug and 
the lifespan, or they can cause unwanted side effects. The quality assurance of herbal formulations is 
the main concern of current phytomedical era due to the increase in toxicity reports. As a 
consequence, both organic and inorganic (elemental) impurities must be monitored and controlled 
in final dosage form starting from the raw materials itself. This article deals with the various aspects 
of heavy metals in Ayurvedic medicines such as their sources, methods used for their determination, 
their therapeutic significance, their toxic effects and also summarizes various guidelines and limits 
for their regulation. 
KEYWORDS: Ayurvedic medicine, Heavy metals, Standardization, Significance, Toxicity, 
Permissible limits. 
INTRODUCTION
 The traditional Indian systems, which may 
also be called as Indian systems of Medicine (ISM), 
have a very solid conceptual basis and have been 
practiced continuously for a long time; therefore, 
they are considered as independent medical systems. 
Ayurveda, Siddha and Unani are the three important 
traditional systems practiced in India. Ayurveda is 
the oldest and most practiced system among the 
three with a consolidated history of many centuries. 
Ayurveda involves utilization of natural elements for 
elimination of root cause of the ailment by 
restoration of balance and creation of a healthy 
lifestyle in order to prevent its repetition.[1,2] The 
term Ayurveda is derived from two Sanskrit words in 
which AYU means life and VEDA means knowledge 
of. So, Ayurveda means having the ‘knowledge of life’. 
According to Charaka, the ancient Ayurvedic scholar, 
"Ayu" or life consists of a combination of four 
essential parts: mind, body, soul, and senses. [3] Each 
of these must be nourished if an individual needs to 
have good health.[2] It is known that Ayurveda is a 
complete medical system that includes physical, 
psychological, philosophical, ethical and spiritual 
health and hence also is known as the "Mother of All 
Cures". [2,4] 
 In India there are more than 12,000 
Ayurvedic universities and hospitals and clinics. 
According to the World Health Organization (WHO), 
about 70–80% of the world populations rely on 
nonconventional medicines mainly of herbal sources 
in their healthcare. [4,5] 
The issues that require consideration includes-  
̶ Development of National policy for the regulation 
of Ayurveda in India;  
̶ Regulatory mechanism to control and regulate the 
production, use and certification of manufactured 
drugs in this sector, and 
̶ Streamlining the facilities available for generating 
skilled labor, including clinical and paramedical 
staff, research and development aspects, and 
globalization of the system.  
̶ Also strong emphasis is required to make 
ayurvedic medicines as the prescriptional 
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medicines rather than OTC products in order to 
make safe use and prevent harmful toxic and 
adverse effects of these drugs. [1,6] 
 Today, the world of medicine poses 
complex challenges. Therefore, time requires an 
integrated and pluralistic approach to medical care to 
effectively address this situation. To start fruitful 
dialogues between Ayurveda and modern science, a 
deep understanding of both systems becomes an 
essential prerequisite. [7] 
Relevance of Ayurveda and Herbal Formulations 
1. Herbal formulations are highly effective in a large 
number of diseases due to the presence of 
different phytoconstituents and the effects are 
further improved when compatible herbs are 
formulated together in the PHF (Poly-herbal 
Formulations). 
2. It has been found that Poly-herbal formulations 
have a broad therapeutic range. Most of them are 
also effective at low doses and are safe at high 
doses, so they have a greater benefit ratio. 
3. They produce fewer side effects than allopathic 
drugs. Although modern allopathic drugs are 
designed for effective therapeutic results, most of 
them have undesirable side effects such as 
insomnia, vomiting, fatigue, and so on. 
4. Since PHFs are a product of nature, they are 
relatively cheaper, more environmentally friendly 
and readily available than allopathic medicines. 
Due to this, they are in demand around the world, 
especially in rural areas and in some developing 
countries, where expensive modern treatments 
are not available. [2] 
5. They have better tolerance and patient 
acceptance. 
6. Medicinal plants have a renewable source of 
cheaper medicines. 
7. There are tremendous Improvements in the 
quality, effectiveness and safety of medicinal 
herbs with the development of science and 
technology. 
8. They are more effective than any synthetic drug 
around the world. Herbal medicines have 
provided many of the most powerful medicines to 
the vast arsenal of medicines available for 
modern medical science, both raw and purely 
chemical, on which modern medicine is built. [8] 
All the above reasons: effectiveness, safety, low cost, 
ubiquity, and better acceptance, have made 
Ayurvedic formulations an ideal treatment option, 
therefore providing greater patient compliance and 
an excellent therapeutic effect.[2] 
 
Problems Associated With the Use of Herbal 
Formulations 
1. There is a strong misconception that ayurvedic 
formulation is always safe, which is not true. 
CharakaSamhita has described that Ayurvedic 
medicines have adverse effects when prepared or 
used inappropriately. 
2. Concomitant use of PHF with allopathic drugs has 
increased as most of the patients do not tell their 
doctors about concurrent treatments.  
3. Clinical reproducibility of ayurvedic herbal 
formulation is difficult to obtain.  
4. Ingredients of raw materials may vary depending 
on geographical location, climatic conditions, 
environmental hazards, collection methods and 
collection protocols, etc. So it is not easy to 
standardize the final product for a reproducible 
quality. This lot-to-lot variation would directly 
affect the effectiveness and safety of the PHF.  
5. The need to modify the dosage regimen for the 
therapeutic effect needed also seems to be hectic 
as the dose needs to be calculated on the basis of 
whether crude drug or extract is used.  
6. The toxicity of ayurvedic herbal formulas is 
prevalent but remains unresolved. It is well 
known that the presence of heavy metals in 
pharmaceuticals is not permitted, even in small 
quantities, to avoid toxicity. Drug experts estimate 
that around 6,000 drugs in the "Ayurvedic form" 
intentionally contain at least one metal, mercury 
and lead with the most commonly used. It is 
known that these toxic elements are potent 
nephrotoxic, hepatotoxic, neurotoxic and 
hematopoietic agents. 
7. In India, considering that most ayurvedic PHFs are 
manufactured and exported, Ayurvedic herb 
preparation regulation is a bit less rigid, despite 
the establishment of the Drugs Act and the 
Cosmetic Act to control production control and 
quality. According to good clinical practice, 
toxicity studies and clinical studies on plant 
formulations are not mandatory for the 
application of patents and licenses to manufacture 
Ayurvedic herbal based products.[2,9] 
8. Ayurvedic HMPs (Herbal Medicinal Products) are 
marketed as dietary supplements, they are 
regulated under the Dietary Supplement Health 
and Education Act (DSHEA), which does not 
require proof of safety or efficacy and hence 
bypasses the stringent quality tests of Drugs and 
Cosmetics Act 1940.  
9. Generally cGMP are not given due consideration 
while manufacturing of Ayurvedic products hence 
it becomes necessary to continuously monitor the 
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processes in order to keep a check on adulteration 
and substitution. 
10. Other considerations include toxic herbs, 
contamination with heavy metals, microbial 
organisms and pesticides as well as deliberate 
adulteration with pharmaceutical products. [10] 
Regulations for Herbal Medicines 
 In addition to its use by more than 80% of the 
Indian population, Ayurvedic medicine and other 
traditional medicines from India are widely available 
all over the world.[6] Countries have their own set of 
laws and regulations for herbal as well as traditional 
medicines. WHO recommends that each country or 
area must adopt a regulatory system to manage the 
appropriate use of herbal medicine.[11] 
 In the United States, most herbal medicinal 
products from India are marketed as dietary 
supplements under the Dietary Supplement Health 
and Education Act of 1994. The Act does not require 
the submission of safety data or effectiveness for 
marketing approval. Manufacturers do not need to 
register their products with the United States Food 
and Drug Administration (FDA) or get approval 
before producing or selling food supplements. The 
FDA is responsible for taking action against 
potentially unsafe food supplements after it has hit 
the market. 
 However, in the European Union (EU), the 
request for authorization of traditional drugs to 
market requires bibliographic evidence and 
preclinical safety data (such as toxicological and 
pharmacological test data). According to the 
Traditional Medicinal Products Directive (2004/24 / 
EC), in order to obtain traditional registration for use, 
the applicant must submit quantitative and 
qualitative data on the components of the medicinal 
product, a description of the manufacturing methods, 
therapeutic indications, contraindications, adverse 
reaction, dosage, form and route of administration 
[Article 8 (3) (a) - (h), (j) and (k)]. The application 
also requires a summary of product characteristics 
without the clinical data specified in Article 11 (4) of 
Directive 2001/83/EC. In these circumstances, 
medicinal herbs will only be allowed if they can 
successfully overcome a complete regime requiring 
safety and efficacy data. It is likely to be very 
expensive for most medicinal herb manufacturers in 
India. [12] 
 In India, traditional herbal medicines, such 
as Ayurveda, Siddha and Unani (ASU), are considered 
safe due to its long history of use. As such, no safety 
and efficacy studies are required for marketing 
approval, according to the Drug and Cosmetics Act 
1940 (DCA). IMCC (Indian Council Medical Center) 
Act, Research Tips (ICMR and CSIR), Department of 
AYUSH (Ayurveda, Yoga and Naturopathy, Unani, 
Siddha and Homeopathy) and the Drug Act and 
Cosmetic Act 1940 (Amendment) regulate medicinal 
herbs in India. [11] 
 When a publication in JAMA[13,14]posted 
warning about the toxic contents of some herbal-
mineral preparations sold on US markets, the AYUSH 
Department took serious note of it. Administrative 
orders prescribing limits on the content of some of 
the minerals / metals were issued and directed the 
state governments and manufacturers to test each 
batch of ASU formulations for the metal content 
which have been intended for export. 
 In 2013, the then Department of AYUSH 
published the "Good Clinical Practice Guidelines for 
Clinical Trials in Ayurveda, Siddha and Unani 
Medicine" which will be followed by investigators, 
sponsors and drug manufacturers during clinical 
trials for ASU interventions. 
 The Ministry of AYUSH is also in the process 
of developing a Schedule Z for ASU drugs on the lines 
of Schedule Y of Drugs and Cosmetics Act for 
Biomedicine drugs. [15] 
 With the advent of the IPR regime, the 
department of AYUSH has also begun digitizing 
traditional medicinal formulations, manuscripts and 
knowledge and documentation, and promoting local 
health traditions. The Digital Library of Traditional 
Knowledge (TKDL) is a database containing codified 
literature of Indian medicine systems. It is a 
collaborative project between the Council of 
Scientific and Industrial Research (CSIR), the 
Ministry of Science and Technology and the 
Department of AYUSH, the Ministry of Health and 
Family Welfare, and is being implemented in CSIR. 
 Recently some regulatory guidelines have 
been introduced. The AYUSH Department and 
National Medicinal Plants Board (NMPB) has 
prepared India's Specific Guidelines on Good 
Agricultural Practices (GAPs). In the preparation of 
this standard, assistance has been taken from the 
Good Agricultural Practices and Field Collection 
Practices (GAFCPs) developed by the WHO in 2003 
and Good Agricultural Practices set forth by the 
GLOBALGAP Secretariat which is implemented in 
more than 80 countries. [11] 
Heavy Metals 
 The metals are widely distributed in nature 
and are found freely in soil and water. Heavy metals 
are metallic compounds of natural origin that have a 
high density compared to other metals, at least five 
times the density of water. [16] 
 Considering that heaviness and toxicity are 
inter-connected, heavy metals also include metalloids 
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such as arsenic, which can induce low-level toxicity. 
Heavy metals are also considered trace elements 
because of their presence in trace concentrations 
(ppb range to less than 10 ppm) in different 
environmental matrices.[17]  
 Any toxic metal can be called heavy metal, 
regardless of its atomic mass or density. [18] Any type 
of metal (or metalloid) can be considered a 
"contaminant" if it occurs where it is not desired, or 
in a form or concentration causing a harmful human 
or environmental effect. Metals/Metalloids include 
lead (Pb), cadmium (Cd), mercury (Hg), arsenic (As), 
chromium (Cr), copper (Cu), selenium (Se), nickel 
(Ni), silver (Ag) and zinc (Zn). Other less common 
contaminants include aluminum (Al), cesium (Cs), 
cobalt (Co), manganese (Mn), Molybdenum (Mo), 
strontium (Sr) and uranium (U). [19] 
Sources of toxic heavy metals in herbal medicinal 
products 
 Exposure to metals has increased 
dramatically over the last fifty years as a result of an 
exponential increase in the use of heavy metals in 
industrial processes and products. In developing 
countries, heavy metal pollution is exacerbated by 
mining, minerals, smelting and the tanning industry.  
Heavy metal contamination is one of the problems 
that arise due to the increased use of fertilizers and 
other chemicals to meet the increased food 
production needs for human consumption and is one 
of the most pressing threats to water and soil, as well 
as to human health. [20] 
The presence of heavy metals in herbal products is 
attributed to different possibilities. 
 Environmental factors can contribute to the 
contamination of these products. It includes the 
contamination of agricultural soils and irrigation 
waters as a result of the elimination of industrial 
waste, mining activities and the use of certain 
types of fertilizers. [21] 
 Natural sources of heavy metals such as the 
transport of volcano emissions from continental 
dust and the erosion of metal-enriched rocks due 
to the long exposure to air greatly increase the 
quantities of medicinal herbs in the soil. 
 Furthermore, herbal medicines can also be 
contaminated by the soil through other human 
activities, such as: (i) the exploitation of mines and 
smelters (ii) the application of metal-based 
pesticides and sewage sludges enriched with 
metals in agriculture (iii) ) combustion of fossil 
fuels, metallurgical and electronic industries, and 
(iv) military training and weapons, etc. [22] 
 Toxic wastewater elements can contaminate 
agricultural land, water supply and the 
environment and thus the human food chain. The 
crops are contaminated and accumulate 
unfavorable levels of metallic elements inside 
them. [23] 
 Heavy metals can also be introduced during the 
preparation of raw materials for herbal products 
that cover many steps, such as growing, 
harvesting, cleaning and drying medicinal plants. 
 The other possibility is accidental contamination 
during the manufacturing process, such as 
grinding, mixing and exposure to heavy metals by 
metal release equipment that could be used at 
different stages of the processing part. 
 Intentional addition of heavy metals during 
preparation as part of the healing ingredients is 
another source of heavy metal contamination. 
 Heavy metals may also be leached into the drug 
substance and drug product from the container-
closure systems. [21] 
Analytical methods used for the quantitative 
determination of heavy metals 
 There are several approaches for the detailed 
analysis of heavy metals in environmental, biological 
and food samples. Analytical methods often require a 
pre-concentration of the sample and / or 
pretreatment for the destruction of the organic 
matrix such as wet digestion, dry ash and dissolution 
or extraction in a microwave oven. It is a huge 
challenge to develop sensitive and selective analytical 
methods capable of quantitatively characterizing 
trace levels of heavy metals in various types of 
samples.Table 1 summarizes the optical and 
electrochemical methods applied for the 
determination of heavy metals. [24] 
Table 1: Most Usual Methods Applied for Determination of Heavy Metals[24] 
Technique Principle Type of analysis Applications 
Atomic absorption 
spectrometry (AAS) 
Absorption of radiant energy 
produced, by a special 
radiation source, by atoms in 
their electronic ground state 
-Single element; 
-Multi-element 
analysis (2-6 
elements) 
Widely used 
Inductively coupled 
plasma with atomic 
emission 
Measures the optical emission 
from excited atoms 
Simultaneous multi-
element analysis 
Widely used method 
for environmental 
analysis 
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spectrometry (ICP-
AES) 
Inductively coupled 
plasma with mass 
spectrometry (ICP-
MS) 
- Argon plasma used as ion 
source; 
-Used for separating ions 
based on their mass-to charge 
ratio 
Simultaneous 
multielement analysis 
-Widely used; 
-Isotope determination 
Atomic fluorescence 
spectrometry (AFS) 
Measures the light that is 
reemitted after absorption 
Single element -Mercury, arsenic, and 
selenium; 
-Complementary 
technique to aas 
X-ray fluorescence 
(XRF) 
-X-rays 
-Primary excitation source; 
-Elements emit secondary X-
rays of a characteristic 
wavelength 
Simultaneous 
determination of most 
elements 
 
-Non-destructive 
analysis; 
-Less suitable for 
analysis of minor and 
trace elements 
Neutron activation 
analysis (NAA) 
-Conversion of stable nuclei of 
atoms into radioactive ones; 
-measurement of the 
characteristic nuclear 
radiation emitted by the 
radioactive nuclei 
Simultaneous 
multielement analysis 
 
 
 
-Most elements can be 
determined; 
-Highly sensitive 
procedure 
Electrochemical 
methods 
-Controlled voltage or current;  
-Polarography;  
-Potentiometry; 
- Stripping voltammetry; 
Consecutive analysis of 
different metal ions 
-Analysis for transition 
metals and metalloids 
(total content or 
speciation analysis) 
Heavy metal toxicity and metals of interest 
 Heavy metal toxicity is the accumulation of heavy metals in toxic quantities in the soft tissues of the 
body which starts affecting the normal functioning of the body. The symptoms and physical findings associated 
with heavy metal toxicity differ depending on the accumulated metal. Many of the heavy metals, such as zinc, 
copper, chromium, iron and manganese, are essential for the functioning of the body in very small quantities. 
But if these metals accumulate in the body in concentrations sufficient to cause toxicity, serious damage can 
occur. [25] 
 In ICH Guidelines, the elemental impurities have been sorted into different categories in order to 
facilitate decisions during the risk assessment. This classification has been summarized in Table -2 below: 
Table2.Elemental Impurity Classfication [ICH Guidelines][26] 
 Included Elemental 
Impurities 
Include in Risk 
Assessment? 
Description 
Class 1  As, Pb, Cd, Hg  Yes   Significantly toxic across all routes of 
administration.  
 Typically have limited or no use in the manufacture 
of pharmaceuticals 
 Can be present as impurities in commonly used 
materials (e.g., mined excipients). 
 Cannot be readily removed from the material. 
Because of their unique nature, require 
consideration during the risk assessment. 
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Class 2  Are toxic to a greater or lesser extent based on route of administration.  
 Some of the elements in this category are infrequently observed as impurities in materials 
used to produce drug products and as such, unless intentionally added have a low probability 
of inclusion in the drug product and do not present a significant risk.  
 Are further categorized to establish when they should be considered in the risk assessment 
and when their contribution can be judged to be negligible. 
Class 2A  V, Mo, Se, and Co  Yes  These require assessment across all potential sources 
and routes of administration due to their higher 
relative natural abundance (US Geological Survey, 
2005). 
Class 2B  Ag, Au, Tl, Pd, Pt, Ir, 
Os, Rh, and Ru 
Yes only if 
intentionally 
added  
These require assessment only if they are 
intentionally added to the processes used to generate 
the material under evaluation. 
Class 3  Sb, Ba, Li, Cr, Cu, Sn, 
Ni  
Dependent upon 
route of 
administration  
 These are impurities with relatively low toxicity 
(high PDEs) by the oral route administration but 
require consideration in the risk assessment for 
other routes of administration (e.g., inhalation and 
parenteral routes).  
 For oral routes of administration, unless 
intentionally added as part of the process 
generating the material, they do not need to be 
considered during the risk assessment.  
 For parenteral and inhalation products, the 
potential for inclusion of these impurities should 
be evaluated during the risk assessment.  
Class 4  B, Fe, Zn, K, Ca, Na, 
Mn, Mg, W, Al  
No   These are the impurities that have been evaluated 
but for which a PDE has not been established due 
to their low inherent toxicity and/or regional 
regulations.  
 If these elemental impurities are present or 
included in the drug product they are addressed 
following the practices defined by other guidelines 
and regional regulation.  
    
 Since lead, arsenic, cadmium and mercury 
are considered as the most toxic heavy metals for 
human health; hence the discussion here is focused 
on these metals. Table 3 summarizes various aspects 
of heavy metals which are likely to contaminate 
ayurvedic formulations and are highly toxic even in 
small concentrations. 
Important aspects of toxic heavy metals 
responsible for toxicity found present in 
Ayurvedic preparations [26-37] 
Arsenic 
 Arsenic (As) is ubiquitous in the environment 
and present in food, soil, drinking water and in air 
and forms a variety of compounds, either inorganic 
or organic. Inorganic As occurs in trivalent (e.g., 
arsenic trioxide, sodium arsenite) or pentavalent 
forms (e.g., sodium arsenate, arsenic pentoxide, 
arsenic acid) which are generally known to be more 
toxic and are mainly of geological origin. Organic 
Arsenic compounds like Arsenobetaine, Arseno-
choline, Arsenosugars and Tetramethylarsonium 
salts contain carbon and are mainly found in sea-
living organisms. [38,39] 
Source of exposure: Certain arsenicals are used as 
pesticides, fungicides and rodenticides, or used in 
glass, electroplating, dyestuff, paint and cosmetic 
industries as well as in semiconductor 
manufacturing. Coal-burning in power plants and 
smelters is the largest source of industrial arsenic. 
Route of absorption: It includes Inhalation by lungs 
(arsine), Ingestion by GIT, and Absorption through 
skin. 
Form of absorption: Inorganic salt or arsine gas  
Distribution/targets: The distribution mainly 
depends on administration and type of arsenic 
compound involved. It is mainly stored in RBC (24 h), 
Liver, Kidneys, Lungs, Spleen, Muscles, CNS (4 
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weeks), Bone, Skin, Hair (an year), and can cross the 
placenta 
Plasma t1/2: 
̶ Inorganic: ∼10 h, 30 h, 200 h (tri-phasic)  
̶ Organic: ∼1 h 
Excretion: The excretion is very slow and is mainly 
through urine and feces in man and may also 
bethrough sweat, milk and hair. 
Toxicity mechanism: Arsenic (trivalent) binds to 
and inhibits SH-enzymes (sulfhydryl enzymes) by 
reacting with biological ligands having sulfhydryl 
groups.  
Pharmacological action: It acts as an Antisyphilitic 
and antipyretic in certain febrile diseases. It is also 
helpful in treatment of certain skin diseases. Organic 
arsenicals are also used in the treatment of 
trypanosomiasis. 
Therapeutic uses 
Inorganic: It was used predominantly in leukemia, 
psoriasis, and chronic bronchial asthma in early 
times. Also beneficial in eczema and has antipyretic 
effect in certain febrile diseases. 
Organic: Organic arsenic antibiotics were used 
extensively in the first half of the twentieth century, 
principally in the treatment of spirochetal and 
protozoal diseases and also in the treatment of 
syphilis.  
Adverse reactions/ toxicity 
Acute: Nausea, abdominal pain, laryngitis, bronchitis, 
vomiting and severe diarrhea. As fluid loss increases 
symptoms of shock appear. In severe poisoning death 
may occur in 1 h. If patient survives the acute 
episode, bone marrow suppression, encephalopathy 
and crippling sensory neuropathy may follow. 
Chronic: It is usually due to inorganic arsenic and 
manifests as skin irritation and hair loss, sensory 
neuropathy, bone marrow depression, fatty liver, 
nephropathy, GIT irritation, etc. 
Laboratory investigation: Arsenic can be measured 
in whole blood or urine, but the latter is to be 
preferred. The identification of stable non-toxic 
arsenic species, such as arsenobetaine, derived from 
dietary seafood is more difficult than measurement of 
total arsenic, but their presence can make the 
confirmation of arsenic poisoning from total arsenic 
measurements difficult. 
Common Companion Testing: Fractionation or 
speciation. 
Management of toxicity 
Acute: Treatment consists of gastric lavage, i.v. fluids, 
correction of electrolyte balance and supportive care. 
In severe cases Dimercaprol 3-5 mg/kg i.m. every 4 h 
for 48 h is given. 
Chronic: The intravascular volume is maintained. 
Dimercaprol is administered in a dose of 3 mg/kg i.m. 
every 4 h until abdominal symptoms subside. 
Penicillamine is substituted orally for Dimercaprol 
and continued for 4 days. The adverse effects of 
chelating agents limit the usefulness of the therapy. 
In severe arsenic-induced neuropathy dialysis is 
indicated.  
Permissible limits [WHO]: 3 ppm  
Cadmium 
Cadmium (Cd) is a transition metal whose most 
abundant naturally-occurring isotope is non-
radioactive. It is found in nature in mineral forms and 
is obtained for commercial uses principally from 
cadmium ore. Cadmium exists as a salt form in the +2 
oxidation state only. Cadmium, cadmium oxide, 
cadmium salts on borosilicate carrier is used as 
catalysts in organic synthesis. Silver cadmium alloy is 
used in the selective hydrogenation of carbonyl 
compounds. 
Source of exposure: Cadmium is often found near 
sites of metal mining and refining, production and 
application of phosphate fertilizers, waste 
incineration, and disposal. Occupational exposure is 
linked to battery, smelting, and electroplating 
industries. Also used in plastics and paint pigments. 
Cigarette smoking contributes to cadmium intake 
significantly.  
Route of absorption: Absorption mainly occurs 
through lungs. It is poorly absorbed via- GIT and skin. 
Distribution/targets: About 50 % of the total 
amount is deposited in Kidneys and Liver and is also 
stored in respiratory tract and bones. 
Plasma t1/2:1 month, 10–20 yrs (bi-phasic)  
Excretion: The excretion is very slow and is mainly 
through feces. Urinary excretion becomes significant 
when there is significant renal damage. 
Toxicity mechanism: Cadmium binds to cystein-rich 
low molecular weight protein such as 
metallothionein found in liver and kidneys. It also has 
the capability to bind with glutamate, histidine and 
aspartate ligands and can lead to the deficiency of 
iron. 
Adverse reactions/ toxicity: Dyspnea, Emphysema, 
Pulmonary fibrosis, Glycosuria, Aminoaciduria, 
proteinuria, Hypertension, Itai-Itai disease 
(osteoporosis and osteomalacia). 
Laboratory investigation: Both whole blood and 
urine concentrations are necessary for the 
assessment and monitoring of chronic cadmium 
exposure, as 90% of Cd is bound to erythrocytes and 
has a half-life of 70-120 days. The blood 
concentration depends on both current exposure and 
body burden and is generally a better guide to the 
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former than is urine Cd, unless the body burden is 
high. Urinary Cd excretion is positively correlated 
with cumulative exposure and with renal and hepatic 
concentrations 
Common Companion Testing: Urine ß2-
microglobulin  
Management of toxicity: There is no effective 
therapy for Cd toxicity. Therapy with Calcium 
disodium EDTA (Ca Na2 EDTA) 75 mg/kg per day in 
three to six divided doses is given for 5 days. The 
total dose should not exceed 500mg/kg per 5 day 
course. 
Permissible limits (WHO): 0.3 ppm 
Lead (Naga) 
 Lead (Pb) is the most common heavy element. 
It occurs in organic and inorganic forms. The 
generally bivalent Pb compounds include water-
soluble salts such as Lead acetate as well as insoluble 
salts such as Lead oxides. Organic Pb compounds 
include the gasoline additives tetramethyl- and 
tetraethyl-lead. Organic Pb compounds undergo 
fairly rapid degradation in the atmosphere and form 
persistent inorganic Pb compounds in water and soil.  
Source of exposure: Lead toxicity constitutes the 
oldest occupational disease in the world. Lead is 
widely used in industries e.g. in paints, battery, 
casings, illicit distillation, pipes, gasoline, etc. in 
addition, many lives in a lead-containing 
environment (air, food and water).  
Route of absorption: Absorbed mainly through 
inhalation by lungs, ingestion by GIT and to some 
extent also from the skin. 
Form of absorption: Metallic lead, inorganic or 
organic salts 
Distribution/targets: After absorption lead is bound 
to RBC (24 h) and distributed to soft tissues (Liver, 
Kidneys, muscles, spleen, brain, bone marrow, etc.) 
and then to skin, hairs, nails and bones and can also 
crosses placenta. 
Plasma t1/2:30 days  
Excretion: Excretion is very slow; and is primarily in 
stool; absorbed lead is excreted in urine, sweat and 
mother’s milk. 
Toxicity mechanism: Lead binds to –SH enzymes 
and forms complex ligands with many compounds 
and interferes with the activity of enzymes. It also 
interferes with actions of cations. 
Pharmacological action: It acts as an Appetizer, 
aphrodisiac, and an immunomodulator. It alleviates 
urinary tract disorders and diseases caused by 
vitiated Vata and Kapha. 
Therapeutic uses: Naga bhasma is indicated in 
Diabetes, rheumatoid arthritis, tetani, fever, anemia, 
dyspnea, cough, emaciation, cachexia, oedema, 
abdominal tumor, bowel syndrome, piles, ulcer, 
diarrhea, etc. it is also prescribed in all water borne 
diseases. 
Therapeutic dose: 1/4th to1 Ratti (30 to 125 mg)/ 
day. 
Adverse reactions/ toxicity 
Acute: Not so common. Manifestations include thirst, 
metallic taste, nausea, vomiting and abdominal pain, 
paresthesias, muscle weakness, haemoglobinuria, 
oliguria and kidney damage.  
Chronic: It affects gastrointestinal, CNS, 
hematopoietic system, kidney and others. The system 
may be affected alone or in combination. CNS is 
affected commonly in children, while the 
gastrointestinal system is affected in adults. 
Laboratory investigation: The 'gold standard' for 
estimating the internal dose of lead has been 
measurement of its excretion after the administration 
of 1g of calcium ethylenediaminetetra-acetic acid 
(EDTA) (as an i.v. infusion or i.m. injection). Excretion 
during the next 24 h of more than 3·9/µmol (800/µg) 
lead in adults, or 2.9-3.4/µmol (600- 700/µg) in 
children, indicates a raised body burden. 
Common Companion Testing: Blood zinc 
protoporphyrin (ZPP), CBC, ∂-amino levulinic acid  
Management of toxicity 
In Ayurveda: Hema (gold) and Powder of Terminalia 
chebula (Haritaki) should be given repeatedly along 
with sugar candy (Sita) for 3 days. 
In Allopathy 
In acute phase supportive measures are given. Fluid 
and electrolyte balance must be maintained. Edetate 
calcium disodium and Dimercaprol are used together 
usually. Former is given in dose of 50-75 mg/kg/day 
in 2 divided doses by i.v. or i.m. injection. 
Dimercaprol is given at a dose of 4 mg/kg every 4 h 
for 48 h the every 6 h for 48 h and every 6-12 h for 
additional 7 days 
Permissible limits (WHO): 10 ppm 
Mercury (Parada) 
 Mercury (Hg) is an element widely existing in 
the global environment. Hg exists in three forms: 
elemental mercury, inorganic mercury and organic 
mercury. Mercury is the only metal which is liquid 
under ordinary conditions. The most likely form of 
residual mercury in drug products is the inorganic 
form. Methyl mercury, the common, poisonous form, 
occurs by methylation in aquatic biota or sediments 
(both freshwater and ocean sediments).  
Source of exposure: Mercury is used in: dental 
amalgams (50% by weight), explosive detonators; 
some vaccines in pure liquid form for thermometers, 
Agarwal Princy et al. Usage of Heavy Metals in Ayurvedic Formulations and its Management: A Review 
     Available online at: http://ijapr.in  41 
barometers, and laboratory equipment; batteries and 
electrodes (“calomel”); and in fungicides and 
pesticides and in the paper industry. Emissions from 
coal fired power plants and hospital/municipal 
incinerators are significant sources of Mercury 
pollution.  
Route of absorption: Absorption is dependent on 
the chemical form of mercury. Absorption of 
elemental mercury is poor but it can be absorbed 
from lungs. Occupational poisoning is mainly due to 
inhalation by Lungs (elemental Hg). Other routes 
include ingestion by GIT and Absorption through 
skin. 
Form of absorption: Metal, Inorganic salt (Hg+2), 
Organic (short chain). 
Distribution/targets: After absorption highest 
concentration of mercury occurs in renal tubules. 
Other targets are CNS, Blood and GIT. 
Plasma t1/2: 
̶ Inorganic: 3 days, 20 days (bi-phasic)  
̶ Methyl mercury: 52 days 
Excretion: Excretion is slow and chiefly through 
urine although some is removed through sweat and 
gastrointestinal tract. 
Toxicity mechanism: Hg+2binds to SH-enzymes and 
gets concentrated in kidneys and CNS. 
Pharmacological action: It is used in a compound 
(Murchita) form. It possesses aphrodisiac and anti-
ageing properties. These increase potentiality, 
intellect, memory, attentiveness, and complexion and 
tissue elements. These eradicate diseases caused by 
all the three humoral principles even restricting 
death. 
Therapeutic uses: Mercurial preparations are used 
in anemia, dyspnea, cough, jaundice, fever, spasmodic 
pain, nephritis, vomiting, acute abdomen, worm 
infestation, diarrhea etc. 
Therapeutic dose: 1 Ratti (125 mg)/ day 
Adverse reactions/toxicity: The improperly 
prepared mercurial preparations may cause various 
ill effects. 
Acute: Shock, gingivitis, nausea, vomiting, 
gastroenteritis, renal failure and liver damage.  
Chronic: Skin disorders, osteoarthritis, stomatitis, 
increased salivation, anorexia, anemia, hypertension, 
multiple neurological disorders and even death. 
Laboratory investigation: The diagnosis of mercury 
poisoning is based on demonstrating concentrations 
higher than the limits for either whole blood or urine 
(early morning or 24 h collection). Urine is however 
easier to measure. It is analytically possible to 
measure total and inorganic mercury separately in 
blood or urine. Urinary mercury reflects exposure 
during the previous 2-3 months; blood mercury with 
its shorter half-life reflects exposure in the preceding 
week. 
Management of toxicity 
In Ayurveda 
 Sulphur is mentioned as a specific drug, other 
remedies are also described like Dhanyaka 
(Coriandrum sativum) with sugar candy or Marich 
(Piper nigrum) with ghee (clarified butter) should be 
given repeatedly for 7 days. 
In Allopathy 
Acute: Dimercaprol is given in dosage of 3-5 mg/kg 
i.m. every hour for 48 h and then every 12 h for 10 
days.  
Chronic: Oral penicillamine or N-acetylpenicillamine 
(250-500 mg orally) four times daily for 10 days. 
Permissible limits [WHO]: 1 ppm 
Therapeutic significance of heavy metals 
 Heavy metals in herbal preparations may not 
only be the result of accidental contamination but 
may be introduced for presumed therapeutic 
properties; For example, mercury has been used to 
treat syphilis until the introduction of penicillin, 
while arsenic derived compounds are still used to 
treat some forms of malignancy. [31]Although the 
biological effects of various metals are well known, 
little is known about their biological activity in terms 
of elemental properties. [27] 
 During the middle ages, with the advent of 
Rasashastra, the use of some heavy metals and 
minerals increased in ayurvedic therapies. 
Rasashastra is an integral part of Ayurveda which 
deals with drugs of mineral origin and details their 
varieties, characteristics, processing techniques, 
properties, therapeutic uses, the ability to develop 
adverse effects and their manipulation, etc. in an 
integral way. [28] 
 The metals used in the Ayurvedic medicine 
system include mercury (Parada), gold (Swarna), 
silver (Rajata), copper (Tamra), iron (Lauha), tin 
(Vanga), lead (Naga), zinc (Yasada) etc. Metal 
Bhasmas are the result of a series of physico-
chemical processes. These are considered easily 
absorbable in humans and produce an optimal 
benefit at a minimum dose. [27] 
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Table 3: Important Aspects of Some Important Heavy Metals Used in Ayurvedic Formulations to Treat 
Various Ailments [27] 
Heavy 
metals 
Pharmacological 
actions 
Therapeutic 
indications 
Therapeutic 
dose 
Adverse 
effects/Toxicity 
Management 
of toxicity 
Gold 
(Swarna) 
Aphrodisiac, cardiac 
stimulant, immuno-
modulator, increases 
potentiality, 
complexion, longevity, 
intellect, memory and 
attentiveness, in 
management of 
poisoning. It alleviates 
disorders caused by all 
the three vitiated 
Doshas. 
Tuberculosis, 
schizophrenia, 
fever, grief, 
anemia, dyspnea, 
cough, worm 
infestation, 
anorexia, 
ophthalmic 
disorders and in 
poisoning. 
1/8th to 1/4th 
Ratti (15 to30 
mg)/ day 
Weakness, 
impotency, leads to 
imbalance of 
homeostasis and 
even death. 
Powder of 
Terminalia 
chebula fruit 
should be given 
repeatedly 
along with 
sugar candy 
(Sita) for 3 
days. 
Silver 
(Rajata) 
Aphrodisiac, anti-
ageing, scraping, 
immunomodulator 
properties, increases 
potentiality and 
intellect. It eradicates 
diseases caused by all 
three vitiated Doshas. 
Diabetes, vitiligo, 
tuberculosis, 
anemia, dyspnea, 
cough, ophthalmic 
disorders, piles, 
thirst, emaciation 
and in poisoning. 
1/4th to 1 Ratti 
(30 to125 mg)/ 
day. 
Anemia, itching, 
fever, constipation, 
cervical 
lymphadenopathy, 
oligospermia, 
weakness, 
headache and 
reduce potency. 
Sugar and 
honey should 
be given 
repeatedly for 
3 days. 
Copper 
(Tamra) 
Rejuvenator, wound 
healer, emaciator, 
purgative and 
immunomodulator. 
It alleviates disorders 
caused by Kapha and 
Pitta. 
Fever, anemia, 
dyspnea, cough, 
worm infestation, 
emaciation, 
anorexia, 
dyspepsia, 
abdominal tumor, 
splenic disorder, 
liver disorder, 
fainting, 
spasmodic pain, 
peptic ulcer, 
ascitis, diabetes, 
bowel syndrome, 
piles, rhinorrhea, 
acidity, etc. 
1/8th to ½ 
Ratti (15 - 60 
mg)/ day. 
Vomiting, fainting, 
hallucination, 
perspiration, skin 
disorders, 
spasmodic pain, 
hyperlipidemia, 
burning sensation, 
delirium, anorexia, 
ill health, 
weakness, 
impotency, leads to 
lack of complexion 
and even death. 
Powder of 
Coriandrum 
sativum 
(Dhanyaka) 
fruit or 
Sesbania 
grandiflora 
(Munivrihi) 
should be given 
repeatedly 
along with 
sugar candy 
(Sita). 
Iron 
(Lauha) 
Aphrodisiac, anti-
ageing, emaciating, 
immunomodulator 
properties, increases 
potentiality, 
complexion and 
appetite. 
It eradicates diseases 
caused by vitiated 
Kapha and Pitta. 
Anemia, diabetes, 
tuberculosis, piles, 
skin disorders, 
worm infestation, 
cachexia, obesity, 
bowel syndrome, 
splenic disorders, 
hyperlipidemia, 
dyspepsia, 
spasmodic pain, 
and also in 
poisoning. 
1/4th to 2 Ratti 
(30 to 250 mg)/ 
day. 
Angina, skin 
disorders, 
urolethiasis, 
spasmodic pain, 
burning sensation, 
weakness and even 
death. 
Powder of 
Embelia ribes 
fruit should be 
given 
repeatedly with 
the Juice of 
Sesbaniagrandi
flora leaves and 
patients should 
be exposed to 
sunlight. If 
worm 
infestation 
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occurs, then 
patient should 
be purgated by 
giving the fruit 
pulp of Cassia 
fistula. If 
patients 
complain of 
spasmodic 
pain, then 
Abhraka 
Bhasma and 
Powder of 
Embelia ribes 
fruit with juice 
of Embelia ribes 
fruit or Powder 
of Elletoria 
cardamomum 
seeds should be 
given 
repeatedly. 
Tin 
(Vanga) 
Aphrodisiac, 
rejuvenator, appetizer, 
digestive, immuno-
modulator properties, 
increases potentiality, 
complexion, and 
intellect.  
It eradicates diseases 
caused by vitiated 
Kapha and Pitta. 
Diabetes, 
hyperlipidemia, 
anemia, dypnea, 
cough, ophthalmic 
disorders, worm 
infestation, 
emaciation, 
flatulence and in 
oligospermia. 
1 to 2 Ratti 
(125 to 250 
mg) / day. 
Diabetes, skin 
disorders, 
abdominal tumor, 
cardiac diseases, 
spasmodic pain, 
piles, gout, goiter, 
cough, dyspnea, 
weakness and 
vomiting. 
Powder of 
Mesashringi 
(Gymnema 
sylvestre) fruit 
should be given 
with sugar 
candy 
repeatedly for 
3 days. 
Zinc 
(Yasada) 
Ophthalmic nourisher, 
immunomodulator, 
increases strength, 
potentiality, and 
intellect. 
It alleviates diseases 
caused by vitiated 
Kapha and Pitta. 
Diabetes, anemia, 
dyspnea, cough, 
emaciation, ulcer, 
depression, 
tremor, 
ophthalmic 
disorders etc. 
½ to 1 Ratti (60 
to125 mg)/ 
day. 
Diabetes, 
indigestion, 
vomiting, 
hallucination etc. 
Powder of 
green 
Terminalia 
chebula (Vala 
Haritaki) 
should be given 
repeatedly 
along with 
sugar candy 
(Sita) for 3 
days. 
Permissible Limits for Heavy Metals in Various Regulatory Guidelines 
According to Ayurvedic Pharmacopoeia [38] 
Table 4: Permissible Limits According to Ayurvedic Pharmacopoeia 
S.No. Heavy Metal contents Permissible limits 
1.  Lead 10 ppm 
2. Arsenic 3 ppm 
3.  Cadmium 0.3 ppm 
4.  Mercury 1 ppm 
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Examples of national limits for arsenic and toxic metals in herbal medicines and products (WHO 
guidelines) [39] 
Table 5: Permissible Limits According to Who Guidelines 
 Arsenic 
(As) 
Lead 
(Pb) 
Cadmium  
(Cd) 
Chromium 
(Cr) 
Mercury 
(Hg) 
Copper 
(Cu) 
Total toxic 
metals as lead 
For herbal medicines 
Canada Raw HM 5 ppm 10 ppm 0.3 ppm 2 ppm 0.2 ppm   
Finished HP 0.01 
mg/day  
0.02 
mg/day 
0.006 
mg/day 
0.02 
mg/day 
0.02 
mg/day 
  
China HM 2 ppm 10 ppm 1 ppm   0.5 ppm  20 ppm 
Malaysia  Finished HP 5 mg/kg 10 mg/kg   0.5 mg/kg   
Republic of 
Korea  
HM       30 ppm 
Singapore Finished HP 5 ppm 20 ppm   0.5 ppm 150 ppm  
Thailand HM and 
Finished HP 
4 ppm 10 ppm 0.3 ppm     
WHO recommendations (2)  10 mg/kg 0.3 mg/kg     
For other herbal products  
National Sanitation 
Foundation draft proposal 
(Raw DS)a 
5 ppm 10 ppm 0.3 ppm  2 ppm    
National Sanitation 
Foundation draft proposal 
(Finished DS)a 
0.01 
mg/ day 
0.02 
mg/day 
0.006 
mg/day 
0.02 
mg/day 
0.02 
mg/day 
  
aDietary supplement; HM: Herbal Materials; HP: Herbal Products; DS: Dietary Supplement 
Permitted Daily Exposures and Permitted Concentrations for Elemental Impurities [ICH Guidelines] [26] 
Table 6: Permissible Limits According To ICH Guidelines 
Element Class Oral Route 
µg/day 
Parenteral Route 
µg/day 
Inhalation Route 
µg/day 
PDE PC PDE PC PDE PC 
As 1 15 1.5 15 1.5 1.9 0.29 
Cd 1 5.0 0.50 6.0 0.60 3.4 0.34 
Hg 1 40 4.0 4.0 0.40 1.2 0.12 
Pb 1 5.0 0.50 5.0 0.50 5.0 0.50 
Co 2A 50 5.0 5.0 0.50 2.9 0.29 
Mo 2A 180 18 180 18 7.6 0.76 
Se 2A 170 17 85 8.5 140 14 
V 2A 120 12 12 1.2 1.2 0.12 
PDE: Permitted daily exposure 
PC: Permitted Concentrations of Elemental Impurities in drug products, drug substances and excipients with 
daily doses of not more than 10 grams per day. 
Acceptable limits for elemental impurities according to Quality of Natural Health Products Guide, Canada. [40] 
Table 7: Permissible Limits According to Quality of Natural Health Products Guide, Canada 
Element Adult Limit per 
day 
Limit per day per kg 
body weight 
Limit in parts per million 
(ppm) for Topical Products 
Total Arsenic  
OR Inorganic Arsenic  
Organic Arsenic 
< 10.0 µg/ day 
< 2.1 µg/ day  
< 1.4 mg/ day 
< 0.14 µg/kg b.w./day  
< 0.03 µg/kg b.w./day  
< 20 µg/kg b.w./day 
3 ppm 
Cadmium < 6.0 µg/ day < 0.09 µg/kg b.w./day 3 ppm 
Lead < 10.0 µg/ day < 0.14 µg/kg b.w./day 10 ppm 
Total mercury < 20.0 µg/day < 0.29 µg/kg b.w./day 1 ppm 
Methyl mercury < 2.0 µg/daya < 0.029 µg/kg b.w./daya  
Antimony - - 5 ppm 
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a- Methyl mercury determination is not necessary when the content for total mercury is less than the limit 
for methyl mercury. 
Established oral limits for toxic heavy metals by various organizations [40] 
Table 8: Permissible Limits According to Various Organizations 
 Established oral limits (µg/day) 
  Arsenic Cadmium Lead Mercury 
L
im
it
 f
o
r 
fi
n
is
h
e
d
 
p
ro
d
u
ct
: d
a
il
y
 
d
o
se
 
AHPA (American Herbal Products Association)  10 4.1 10 2.0 
NSF(National Science Foundation) /ANSI 173 
(American National Standards Institute ANSI 
173) 
10 6 20 20 
Canada Natural Health Products Directorate 10 6 20 20 
California Prop 65 Reproductive Toxin None set 4.1 0.5 - 
California Prop 65 Carcinogen 10 - 15 - 
L
im
it
 f
o
r 
to
ta
l 
d
a
il
y
 c
o
n
su
m
p
ti
o
n
 US Agency for Toxic Substances and Disease 
Registry (ATSDR) 
20 14 - 20 
US Environmental Protection Agency (EPA) 20 70 - 7 
US FDA Tolerable Daily Intake 130 55 75 - 
Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) 
150 70 250 16 
European Union - 70 250 16 
 
CONCLUSION 
 Herbal medicinal products are consumed by a 
wide range of the world population of which some 
contain toxic materials such as heavy metals either as 
a therapeutic agent or as a contaminant. The 
presence of heavy metals above the prescribed limits 
in these medications could expose the consumers to 
different adverse health effects. Therefore, a proper 
general awareness should be provided to consumers 
and producers to minimize this risk. The Rasa-
Shastras should be thoroughly studied and its 
principles should be implemented for proper 
processing of heavy metals in these medicines. Today 
patients indulge in self-medication without proper 
prescriptions, which should also be checked and 
discouraged.  
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